Citigroup’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,495
| Closed | -$164K | – | 5674 |
|
|
2023
Q2 | $164K | Hold |
2,495
| – | – | ﹤0.01% | 3988 |
|
|
2023
Q1 | $159K | Hold |
2,495
| – | – | ﹤0.01% | 3850 |
|
|
2022
Q4 | $345K | Buy |
2,495
+495
| +25% | +$69.7K | ﹤0.01% | 3405 |
|
|
2022
Q3 | $253K | Buy |
+2,000
| New | +$226K | ﹤0.01% | 3664 |
|
|
2021
Q1 | – | Sell |
-3,659
| Closed | -$2.05M | – | 6308 |
|
|
2020
Q4 | $2.05M | Buy |
3,659
+1,991
| +119% | +$1.26M | ﹤0.01% | 2835 |
|
|
2020
Q3 | $1.17M | Buy |
1,668
+8
| +0.5% | +$6.24K | ﹤0.01% | 3130 |
|
|
2020
Q2 | $1.31M | Buy |
1,660
+278
| +20% | +$210K | ﹤0.01% | 3257 |
|
|
2020
Q1 | $823K | Sell |
1,382
-1,034
| -43% | -$1.01M | ﹤0.01% | 3384 |
|
|
2019
Q4 | $2.75M | Buy |
2,416
+23
| +1% | +$25K | ﹤0.01% | 2651 |
|
|
2019
Q3 | $2.85M | Sell |
2,393
-1,953
| -45% | -$2.98M | ﹤0.01% | 2483 |
|
|
2019
Q2 | $7.16M | Buy |
4,346
+123
| +3% | +$213K | 0.01% | 1661 |
|
|
2019
Q1 | $8.61M | Sell |
4,223
-988
| -19% | -$1.74M | 0.01% | 1372 |
|
|
2018
Q4 | $6.7M | Buy |
5,211
+77
| +1% | +$118K | 0.01% | 1581 |
|
|
2018
Q3 | $9.71M | Sell |
5,134
-1,359
| -21% | -$2.81M | 0.01% | 1304 |
|
|
2018
Q2 | $13.2M | Buy |
6,493
+1,452
| +29% | +$3.31M | 0.01% | 1078 |
|
|
2018
Q1 | $11.2M | Sell |
5,041
-6,801
| -57% | -$17.3M | 0.01% | 1158 |
|
|
2017
Q4 | $27.3M | Buy |
11,842
+8,484
| +253% | +$17.2M | 0.02% | 690 |
|
|
2017
Q3 | $5.97M | Sell |
3,358
-440
| -12% | -$615K | ﹤0.01% | 1592 |
|
|
2017
Q2 | $5.17M | Buy |
3,798
+1,135
| +43% | +$1.37M | ﹤0.01% | 1669 |
|
|
2017
Q1 | $3.14M | Sell |
2,663
-47
| -2% | -$47.9K | ﹤0.01% | 2052 |
|
|
2016
Q4 | $2.17M | Sell |
2,710
-1,528
| -36% | -$1.21M | ﹤0.01% | 2845 |
|
|
2016
Q3 | $3.72M | Buy |
4,238
+378
| +10% | +$274K | ﹤0.01% | 1939 |
|
|
2016
Q2 | $2.17M | Buy |
3,860
+2,586
| +203% | +$1.46M | ﹤0.01% | 2281 |
|
|
2016
Q1 | $701K | Sell |
1,274
-571
| -31% | -$351K | ﹤0.01% | 3757 |
|
|
2015
Q4 | $1.53M | Buy |
1,845
+85
| +5% | +$84.9K | ﹤0.01% | 2694 |
|
|
2015
Q3 | $1.95M | Sell |
1,760
-46
| -3% | -$83.9K | ﹤0.01% | 2463 |
|
|
2015
Q2 | $3.94M | Buy |
1,806
+1,791
| +11,940% | +$3.65M | ﹤0.01% | 1948 |
|
|
2015
Q1 | $24K | Buy |
+15
| New | +$19.8K | ﹤0.01% | 5991 |
|
Other funds holding BLUE
Citigroup's BLUE Position: Q2 2025 in Review
Citigroup sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 7,503 shares — an estimated $36.6K sold.
Citigroup first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $42.9M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Citigroup reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Citigroup sold 7,503 bluebird bio shares in Q2 2025, an estimated $36.6K.
- Citigroup first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
- Citigroup's bluebird bio position peaked at $42.9M in Q2 2018.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.